V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009765 | 310005145 | 1.74 | 56.7 | Curative (C) | null | 2017-12-30 | PEG INTERFERON | 02 | N | 310020267 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 310009766 | 310005146 | 1.67 | 115 | Palliative (P) | 2017-09-07 | 2017-10-05 | Oxaliplatin + Modified de Gramont | N | N | 310020268 | DACARBAZINE |
| 310009767 | 310005147 | 1.82 | null | Palliative (P) | 2013-01-19 | 2013-10-05 | VEDex | N | N | 310020272 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 310009768 | 310005152 | 1.72 | 61 | null | 2016-09-24 | 2017-01-21 | Cetuximab + Radiotherapy Maint | 02 | N | 310021333 | IVE-R |
| 310009769 | 310005154 | 1.74 | 62.3 | Adjuvant (A) | 2016-08-07 | 2016-12-05 | CVP R + ETOPOSIDE | N | N | 310021556 | CYTARABINE HIGH DOSE |
| 310009770 | 310005159 | 1.61 | 60.2 | Curative (C) | 2014-06-28 | 2014-07-02 | Atezolizumab | Y | null | 310023183 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 310009771 | 310005162 | 1.59 | null | Curative (C) | null | 2013-11-27 | Trabectedin | N | N | 310023229 | BCG |
| 310009772 | 310005163 | 1.82 | null | Palliative (P) | null | 2017-03-20 | Bortezomib +/- Dexamethasone | Y | null | 310023230 | PMITCEBO |
| 310009773 | 310005165 | 1.69 | 38.6 | Palliative (P) | 2017-11-17 | 2017-11-18 | CARBOPLATIN + RT | N | N | 310023238 | ECX |
| 310009774 | 310010793 | 1.84 | 171 | Curative (C) | null | 2017-09-26 | Gemcitabine + Oxaliplatin | 02 | null | 310023294 | CVP R |
| 310009775 | 310008263 | null | 79.3 | Palliative (P) | 2016-06-06 | 2016-06-06 | FLUOROURACIL + OXALIPLATIN | N | null | 310023378 | CISPLATIN + VINORELBINE |
| 310009777 | 310005174 | 1.83 | 68.7 | Curative (C) | null | 2017-03-15 | PLUTO TRIAL | 02 | N | 310023407 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310009778 | 310005176 | 1.58 | 125.6 | null | 2014-06-17 | 2014-06-22 | GEMCITABINE + VINORELBINE | N | N | 310023426 | VINBLASTINE |
| 310009779 | 310005178 | 1.63 | null | Curative (C) | 2015-06-26 | 2015-08-16 | Bevacizumab + Oxaliplatin +MdG | N | N | 310023468 | BCG |
| 310009780 | 310005178 | 1.52 | 59.9 | Palliative (P) | 2017-11-22 | 2018-05-17 | Bevacizumab+Carbo+Gemcitabine | 01 | null | 310023468 | TRASTUZUMAB |
| 310009781 | 310005179 | 1.62 | 14.3 | Disease modification (D) | 2015-09-18 | 2015-09-18 | DHAP | null | null | 310023489 | CETUXIMAB |
| 310009782 | 310005181 | 1.73 | 84.5 | Adjuvant (A) | 2015-04-20 | 2015-04-03 | POMALIDOMIDE | N | N | 310023511 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 310009783 | 310005184 | 1.62 | 47.6 | Palliative (P) | 2017-09-29 | 2017-09-29 | Dacarbazine | Y | null | 310023536 | CISPLATIN + TOPOTECAN |
| 310009784 | 310008271 | 1.85 | 58.7 | Palliative (P) | 2016-11-22 | 2016-11-30 | PEG INTERFERON | 02 | N | 310023544 | CHLORAMBUCIL |
| 310009785 | 310005189 | 1.75 | 52 | Palliative (P) | 2013-11-01 | 2013-11-02 | Sunitinib | N | N | 310023603 | PEG INTERFERON |
| 310009786 | 310008274 | 1.57 | 53 | Curative (C) | 2016-07-02 | 2016-07-04 | LANREOTIDE | 02 | N | 310023616 | OXALIPLATIN + MDG |
| 310009787 | 310008274 | 1.6 | 66.3 | Palliative (P) | 2016-11-05 | 2016-11-05 | Doxorubicin 75mg/m2 | N | N | 310023616 | OXALIPLATIN + MDG |
| 310009789 | 310008278 | null | 92.8 | Curative (C) | 2014-09-23 | 2014-10-01 | MITOMYCIN | 2 | N | 310023746 | IVE-R |
| 310009790 | 310005199 | 1.73 | 0 | Curative (C) | 2014-07-29 | 2014-07-30 | Trabectedin | null | null | 310023798 | METHOTREXATE |
| 310009791 | 310005199 | 1.64 | 62.2 | Disease modification (D) | null | 2017-09-06 | VAC | N | N | 310023798 | DOXORUBICIN |
| 310009792 | 310005204 | 1.79 | 75.1 | Palliative (P) | 2018-08-01 | 2018-08-01 | Capecitabine + Cisplatin | null | null | 310023903 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 310009793 | 310008283 | 1.73 | 53.6 | Disease modification (D) | 2016-05-12 | 2016-05-13 | EOX | null | N | 310023925 | TRASTUZUMAB |
| 310009794 | 310005208 | 1.85 | 47.6 | Curative (C) | 2014-04-19 | 2014-04-25 | Temozolomide 150mg/m2 | N | N | 310023994 | ATG |
| 310009795 | 310005211 | 1.6 | 104.8 | null | null | 2016-09-28 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 310023999 | ICE |
| 310009796 | 310005212 | 1.73 | 67.1 | Curative (C) | 2017-02-14 | 2017-02-14 | NIVOLUMAB | 02 | N | 310024014 | TRASTUZUMAB |
| 310009797 | 310005214 | 1.72 | null | Palliative (P) | 2016-02-14 | 2016-03-23 | IVE-R | Y | N | 310024044 | CHOEP |
| 310009798 | 310009920 | 1.8 | 0 | Curative (C) | 2016-12-14 | 2016-12-23 | IPILIMUMAB + NIVOLUMAB | 2 | N | 310024046 | CAPECITABINE |
| 310009799 | 310005216 | 1.55 | 78 | Palliative (P) | 2015-05-05 | 2015-05-08 | ECF | 02 | N | 310024076 | TRASTUZUMAB |
| 310009800 | 310005218 | 1.82 | 91 | Curative (C) | 2014-11-28 | 2014-12-06 | IPILIMUMAB + NIVOLUMAB | Y | N | 310024105 | BEP |
| 310009802 | 310005224 | 1.78 | null | Palliative (P) | 2017-06-12 | 2017-06-13 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | null | 310024150 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310009803 | 310005224 | 1.68 | 76.5 | Disease modification (D) | 2014-10-22 | 2015-03-04 | Topotecan (oral) | N | N | 310024150 | BENDAMUSTINE |
| 310009804 | 310005225 | 1.67 | null | Palliative (P) | 2014-09-06 | 2014-10-21 | CHOEP | 02 | N | 310024177 | LENALIDOMIDE |
| 310009805 | 310008293 | 1.75 | null | Curative (C) | 2015-04-12 | 2014-12-22 | ALEMTUZUMAB + FLUDARABINE | N | N | 310024177 | IFOSFAMIDE |
| 310009806 | 310011744 | 1.62 | null | Curative (C) | 2015-11-04 | 2015-12-17 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | 310024235 | R-EPOCH |
| 310009807 | 310008294 | null | 96.2 | Palliative (P) | 2015-07-11 | 2018-01-03 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | null | Y | 310024239 | CYTARABINE HD + METHOTREXATE HD |
| 310009808 | 310005228 | 1.67 | 52 | null | null | 2014-04-23 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE | N | N | 310024239 | ECX |
| 310009809 | 310005230 | 1.64 | 61 | Palliative (P) | 2016-10-12 | 2016-10-14 | Cytarabine HD + Methotrexate HD | N | N | 310024278 | ABIRATERONE |
| 310009810 | 310010805 | null | 85 | Curative (C) | 2013-07-25 | 2013-07-25 | ECF | 02 | N | 310024290 | ERLOTINIB |
| 310009811 | 310005232 | 1.59 | 54.8 | Palliative (P) | 2014-03-14 | 2014-04-08 | PEG INTERFERON | 02 | N | 310024315 | CEV |
| 310009812 | 310005233 | 1.8 | 85 | Curative (C) | 2016-05-23 | 2016-05-23 | Sunitinib | N | N | 310024324 | DTPACE |
| 310009813 | 310011309 | 1.62 | null | Curative (C) | 2013-10-23 | 2013-11-03 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 310024355 | FEC |
| 310009814 | 310008300 | 1.82 | 65.3 | Palliative (P) | 2017-10-11 | 2018-06-08 | Gemcitabine + Oxaliplatin | N | N | 310024393 | OXALIPLATIN + MDG |
| 310009815 | 310008300 | 0 | 67.9 | Neo-adjuvant (N) | 2017-04-13 | 2017-05-01 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 310024393 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 310009816 | 310011900 | 1.74 | 96.4 | Curative (C) | 2017-04-29 | 2017-05-13 | Irinotecan + Modified De Gramont | N | N | 310024441 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE |
| 310009817 | 310005241 | 1.77 | 64 | Palliative (P) | 2016-08-04 | 2016-08-13 | TOPOTECAN | N | N | 310024459 | MITOMYCIN |